Stephen Incavo, MD
Orthopaedic Surgery · Houston, TXNPI 1316989478
Payments from drug & device makers
Across 282 payments — averaging $15,220 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$2M
- Microport Orthopedics Inc$1M
- Smith+Nephew$904K
- Osteoremedies, LLC$393K
- Heron Therapeutics, Inc.$335
- Engage Uni, LLC$213
- plus $895 from 12 others
What the payments were for
- Royalty or licence$3,563,93383%
- Consulting fees$91,6432%
- Travel & lodging$19,3350%
- Food & beverage$2,7480%
- Gifts$1140%
- Other$614,27514%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 129 | $1,991,146 |
| Microport Orthopedics Inc | 64 | $1,001,685 |
| Smith+Nephew | 36 | $904,317 |
| Osteoremedies, LLC | 29 | $393,456 |
| Heron Therapeutics, Inc. | 1 | $335 |
| Engage Uni, LLC | 4 | $213 |
| Davol Inc. | 1 | $145 |
| Stryker | 1 | $140 |
| Medacta USA, Inc. | 2 | $135 |
| Amgen | 1 | $122 |
| Shalby Advanced Technologies, Inc. | 1 | $117 |
| Sanofi-aventis U.S. LLC | 4 | $63 |
| Johnson & Johnson | 4 | $57 |
| Vertex | 1 | $40 |
| Bioventus LLC | 1 | $25 |
| Pacira Pharmaceuticals Incorporated | 1 | $21 |
| Pacira Therapeutics, Inc. | 1 | $18 |
| Radius Health, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Persona$1,733,858
- MPO Medial Pivot Knee$992,294
- Engage Partial Knee System$614,389
- Remedy Spacer$466,453
- REDAPT$248,330
- A.L.P.S.$173,827
- Remedy Spectrum GV Spacer$78,175
- ORTHOPEDICS$55,139
- REDAPT Revision Hip System$41,702
- MPO Hip System$8,487
- ROSA-Knee$562
- Zynrelef$335
- PROGEL$145
- MAKO$140
- EVENITY$122
- Robotics-Knees$120
- GMK SPHERE$111
How this compares
$4,292,048 in reported general payments places this provider in the 95th percentile of 1,337 orthopaedic surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 125 | $1,700 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 143 | $1,439 |
| Ondansetron OdtOndansetron | 163 | $1,263 |
| Methylprednisolone | 99 | $731 |
| Doxycycline Hyclate | 25 | $483 |
| Tramadol Hcl | 32 | $89 |
| Amoxicillin | 25 | $46 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Houston
- Stefan KreuzerHouston$7M
- Tiffany HuynhHouston$4.6M
- Thomas EdwardsHouston$4.3M
- Adam FreedhandHouston$1.8M
- Jeffrey KozakHouston$1.1M
- Travis HansonHouston$1M
- David VanderweideHouston$741K
- Thomas TanousHouston$698K
- Alan RechterHouston$605K
- Ugonna IhekweazuHouston$544K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.